An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity

From National Research Council Canada

Download
  1. (PDF, 1.3 MiB)
DOIResolve DOI: https://doi.org/10.1016/j.vaccine.2021.07.034
AuthorSearch for: ORCID identifier: https://orcid.org/0000-0002-4139-0741; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1ORCID identifier: https://orcid.org/0000-0003-0644-6014; Search for: 1; Search for: ; Search for: 1; Search for: ; Search for: ORCID identifier: https://orcid.org/0000-0003-1350-9431; Search for:
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: ISED
FormatText, Article
SubjectSARS-COV-2; vaccine; virus-like-particles; immunogenicity; neutralizing antibodies
Abstract
Publication date
PublisherElsevier
Licence
In
LanguageEnglish
Peer reviewedYes
IdentifierS0264410X21009117
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier8d80f04e-c26e-4ce5-b693-2e491570db49
Record created2022-09-06
Record modified2022-09-06
Date modified: